HLS Therapeutics Inc.
HLTRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,655 | -$27,531 | -$23,598 | -$13,117 |
| Dep. & Amort. | $22,717 | $32,525 | $34,402 | $30,264 |
| Deferred Tax | $3,812 | -$696 | $138 | $1,136 |
| Stock-Based Comp. | $1,617 | -$538 | $2,922 | $2,354 |
| Change in WC | $1,141 | $5,037 | $1,547 | -$3,021 |
| Other Non-Cash | -$1,629 | $5,897 | $1,531 | -$1,187 |
| Operating Cash Flow | $8,003 | $15,789 | $16,942 | $16,429 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15 | -$41 | -$10,148 | -$4,510 |
| Net Acquisitions | -$1,500 | $0 | $0 | -$3,786 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $13,250 | -$148 | -$9,604 | $3,786 |
| Investing Cash Flow | $11,735 | -$189 | -$10,148 | -$4,510 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$21,573 | -$9,463 | -$441 | -$11,137 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$600 | -$1,552 | -$998 | -$47 |
| Dividends Paid | $0 | -$2,398 | -$4,765 | -$5,077 |
| Other Fin. Act. | -$1,191 | -$1,226 | -$455 | $4,908 |
| Financing Cash Flow | -$23,364 | -$14,639 | -$6,856 | -$11,398 |
| Forex Effect | -$870 | $268 | -$394 | $46 |
| Net Chg. in Cash | -$4,496 | $1,229 | -$456 | $567 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,952 | $20,723 | $21,179 | $20,612 |
| End Cash | $17,456 | $21,952 | $20,723 | $21,179 |
| Free Cash Flow | $7,988 | $15,600 | $6,794 | $11,919 |